BRISTOL MYERS SQUIBB FDA Approval NDA 008392

NDA 008392

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #008392

Application Sponsors

NDA 008392BRISTOL MYERS SQUIBB

Marketing Status

Discontinued003

Application Products

003TABLET;ORAL100MG0NYDRAZIDISONIAZID

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 8392
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"NYDRAZID","activeIngredients":"ISONIAZID","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NYDRAZID","submission":"ISONIAZID","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.